Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer

ConclusionTargeted interventions initiated within the first year of diagnosis to preserve or improve SM quality seem warranted for women with ER −MBC.

Source: Breast Cancer Research and Treatment - October 31, 2021 Category: Cancer & Oncology Source Type: research